8 reports

  • VACCINE FOR BIRCH POLLEN ALLERGY - DRUG PROFILE
  • VACCINES FOR BIRCH POLLEN ALLERGY - DRUG PROFILE

The goal was to demonstrate safety and efficacy of recombinant Bet v ## for desensitization against birch pollen allergy.

  • Allergy
  • Allergy Immunotherapy
  • Chronic Disease
  • Therapy
  • Vaccine
  • RGI-1001 - DRUG PROFILE

About ## percent of people who have food allergies are allergic to more than one food.

  • Allergy
  • Chronic Disease
  • Pharmaceutical
  • Therapy
  • Vaccine
  • BM-34 - Drug Profile
  • BM-34 - Drug Profile

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Allergy Drug
  • Allergy Immunotherapy
  • Chronic Disease
  • Vaccine
  • BM-34 - Drug Profile

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Allergy Immunotherapy
  • Chronic Disease
  • Therapy
  • Vaccine
  • RGI-1001 - DRUG PROFILE

BIOLOGIC FOR CEDAR POLLEN ALLERGY - DRUG PROFILE OMALIZUMAB - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description omalizumab F.

  • Allergy
  • Vaccine
  • Japan
  • World
  • Product Initiative

MARKET ##.

  • Vaccine
  • APAC
  • United States
  • World
  • Demand

He has previously spent over six years working at the US Food and Drug Administration (FDA) as a Medical Officer and Medical Team Leader in the Division of Pulmonary-Allergy Drug Products.

  • Vaccine
  • Europe
  • United States
  • Company Financials
  • Allergy Therapeutics plc

The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Vaccine
  • United States
  • Product Initiative